🇺🇸 FDA
Patent

US 10927160

Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof

granted A61KA61K2039/5154A61K2239/57

Quick answer

US patent 10927160 (Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof) held by The Regents of the University of California expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/5154, A61K2239/57, A61K40/11, A61K40/15